ISL
CORT icon

Ingalls & Snyder LLC’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$567M Sell
7,722,922
-19,662
-0.3% -$1.44M 20.11% 1
2025
Q1
$884M Sell
7,742,584
-357,163
-4% -$40.8M 29.09% 1
2024
Q4
$408M Sell
8,099,747
-167,009
-2% -$8.42M 16.01% 1
2024
Q3
$383M Buy
8,266,756
+28,650
+0.3% +$1.33M 14.93% 1
2024
Q2
$268M Sell
8,238,106
-65,041
-0.8% -$2.11M 11.51% 1
2024
Q1
$209M Sell
8,303,147
-48,680
-0.6% -$1.23M 9.24% 1
2023
Q4
$271M Buy
8,351,827
+11,634
+0.1% +$378K 12.26% 1
2023
Q3
$227M Sell
8,340,193
-20,292
-0.2% -$553K 10.94% 1
2023
Q2
$186M Sell
8,360,485
-9,532
-0.1% -$212K 8.91% 1
2023
Q1
$181M Buy
8,370,017
+1,544,755
+23% +$33.5M 9.31% 1
2022
Q4
$139M Sell
6,825,262
-125,815
-2% -$2.56M 7.54% 1
2022
Q3
$178M Sell
6,951,077
-41,171
-0.6% -$1.06M 9.95% 1
2022
Q2
$166M Buy
6,992,248
+80,872
+1% +$1.92M 8.69% 1
2022
Q1
$156M Buy
6,911,376
+173,478
+3% +$3.91M 6.95% 1
2021
Q4
$133M Sell
6,737,898
-315,472
-4% -$6.25M 6.02% 1
2021
Q3
$139M Sell
7,053,370
-17,785
-0.3% -$350K 6.36% 1
2021
Q2
$156M Buy
7,071,155
+124,423
+2% +$2.74M 6.91% 1
2021
Q1
$165M Sell
6,946,732
-355,586
-5% -$8.46M 7.72% 1
2020
Q4
$191M Sell
7,302,318
-189,435
-3% -$4.96M 9.43% 1
2020
Q3
$130M Sell
7,491,753
-107,536
-1% -$1.87M 8.95% 1
2020
Q2
$128M Sell
7,599,289
-404,434
-5% -$6.8M 7.34% 1
2020
Q1
$95.2M Sell
8,003,723
-10,628
-0.1% -$126K 6.41% 1
2019
Q4
$97M Sell
8,014,351
-697,825
-8% -$8.44M 5.25% 2
2019
Q3
$123M Buy
8,712,176
+190,377
+2% +$2.69M 6.01% 1
2019
Q2
$95M Buy
8,521,799
+149,798
+2% +$1.67M 4.57% 2
2019
Q1
$98.3M Sell
8,372,001
-1,888
-0% -$22.2K 4.68% 2
2018
Q4
$112M Sell
8,373,889
-24,371
-0.3% -$326K 5.91% 2
2018
Q3
$118M Buy
8,398,260
+1,081,270
+15% +$15.2M 4.96% 3
2018
Q2
$115M Buy
7,316,990
+499,450
+7% +$7.85M 5.34% 2
2018
Q1
$112M Sell
6,817,540
-106,155
-2% -$1.75M 5.47% 2
2017
Q4
$125M Buy
6,923,695
+44,597
+0.6% +$805K 5.75% 2
2017
Q3
$133M Sell
6,879,098
-433,537
-6% -$8.37M 6.92% 2
2017
Q2
$86.3M Sell
7,312,635
-530,200
-7% -$6.26M 4.68% 3
2017
Q1
$86M Sell
7,842,835
-316,844
-4% -$3.47M 4.59% 2
2016
Q4
$59.2M Sell
8,159,679
-449,750
-5% -$3.27M 3.23% 4
2016
Q3
$56M Sell
8,609,429
-558,811
-6% -$3.63M 3.12% 5
2016
Q2
$50.1M Buy
9,168,240
+89,716
+1% +$490K 2.95% 3
2016
Q1
$42.5M Buy
9,078,524
+63,405
+0.7% +$297K 2.7% 4
2015
Q4
$44.9M Buy
9,015,119
+338,946
+4% +$1.69M 2.87% 5
2015
Q3
$32.6M Buy
8,676,173
+469,190
+6% +$1.76M 2.13% 6
2015
Q2
$49.3M Buy
8,206,983
+274,905
+3% +$1.65M 2.72% 5
2015
Q1
$44.4M Buy
7,932,078
+745,716
+10% +$4.18M 2.45% 5
2014
Q4
$21.6M Buy
7,186,362
+73,604
+1% +$221K 1.25% 17
2014
Q3
$19.1M Buy
7,112,758
+457,685
+7% +$1.23M 1.03% 27
2014
Q2
$18.6M Buy
6,655,073
+155,620
+2% +$436K 0.92% 28
2014
Q1
$28.3M Buy
6,499,453
+999,816
+18% +$4.36M 1.52% 15
2013
Q4
$17.7M Buy
5,499,637
+219,971
+4% +$706K 0.97% 27
2013
Q3
$8.39M Buy
5,279,666
+35,118
+0.7% +$55.8K 0.5% 47
2013
Q2
$9.07M Buy
+5,244,548
New +$9.07M 0.58% 43